{"text": ["Novartis", "Likely", "Delayed", "In", "Launching", "Copycat", "Of", "Amgen", "Blockbuster"], "created_at": "2018-03-29 20:25:05"}
{"text": ["Novartis", "Likely", "Delayed", "In", "Launching", "Copycat", "Of", "Amgen", "Blockbuster"], "created_at": "2018-03-29 20:25:05"}
{"text": ["What\u2019s", "Merck\u2019s", "Valuation", "in", "March", "2018?"], "created_at": "2018-03-29 15:15:02"}
{"text": ["What\u2019s", "Merck\u2019s", "Valuation", "in", "March", "2018?"], "created_at": "2018-03-29 15:15:02"}
{"text": ["Exclusive:", "Penn", "patient", "shares", "the", "story", "of", "her", "CAR-T", "cell", "therapy", "journey"], "created_at": "2018-03-29 15:02:02"}
{"text": ["Exclusive:", "Penn", "patient", "shares", "the", "story", "of", "her", "CAR-T", "cell", "therapy", "journey"], "created_at": "2018-03-29 15:02:02"}
{"text": ["How", "Is", "Novartis\u2019s", "Cosentyx", "Positioned", "after", "4Q17?"], "created_at": "2018-03-29 14:32:58"}
{"text": ["How", "Novartis\u2019s", "Ophthalmology", "Business", "Performed", "in", "2017"], "created_at": "2018-03-29 13:03:01"}
{"text": ["How", "Novartis\u2019s", "Ophthalmology", "Business", "Performed", "in", "2017"], "created_at": "2018-03-29 13:03:01"}
{"text": ["The", "Swiss", "Stock", "Market", "Fell", "On", "Pharma", "Weakness"], "created_at": "2018-03-29 12:13:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Fell", "On", "Pharma", "Weakness"], "created_at": "2018-03-29 12:13:00"}
{"text": ["How", "Merck", "Stock", "Has", "Performed", "Recently"], "created_at": "2018-03-29 12:10:33"}
{"text": ["How", "Merck", "Stock", "Has", "Performed", "Recently"], "created_at": "2018-03-29 12:10:33"}
{"text": ["How", "Did", "Novartis\u2019s", "Affinitor,", "Exjade,", "and", "Tafinlar+Mekinist", "Perform", "in", "2017?"], "created_at": "2018-03-29 11:34:02"}
{"text": ["How", "Did", "Novartis\u2019s", "Affinitor,", "Exjade,", "and", "Tafinlar+Mekinist", "Perform", "in", "2017?"], "created_at": "2018-03-29 11:34:02"}
